Steroid-free immunosuppression in kidney transplantation: An editorial review

American Journal of Transplantation

Volumn 2, Issue 1, 2002, Pages 19-24

  Hricik, Donald E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ASEPTIC NECROSIS; CARDIOVASCULAR DISEASE; CATARACT; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DOSE RESPONSE; DRUG FATALITY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; EDITORIAL; FOLLOW UP; FRACTURE; GLUCOSE INTOLERANCE; HEALTH CARE COST; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; META ANALYSIS; NONHUMAN; OSTEOPENIA; REVIEW; RISK BENEFIT ANALYSIS; SHORT SURVEY; SIDE EFFECT; SUPERINFECTION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; RISK FACTORS;

EID: 0036460894     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.020105.x     Document Type: Short Survey

References (33)

1. Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE. The incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999; 33: 829-839.
2. Hricik DE, Almawi Y, Strom TB. Trends in the use of glucocorticoids in renal transplantation. Transplantation 1994; 57: 979-989.
3. Hricik DE, Schulak JA. Corticosteroid withdrawal after renal transplantation in the cyclosporine era: timing, benefits and risks. Biodrugs 1997; 8: 139-149.
4. Hricik DE, O'Toole M, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993; 4: 1300-1305.
5. Kasiske BL, Chakkera HA, Louis TA, MAJZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11: 1910-1916.
6. Fauci AS. The effect of hydrocortisone on the kinetics of normal human lymphocytes. Blood 1975; 46: 235-240.
7. Almawi WY, Hadro ET, Strom TB. Evidence that glucocorticosteroid-mediated immunosuppressive effects do not involve altering second messenger function. Transplantation 1991; 52: 133-140.
8. Vacca A, Felli MP, Farina AR et al. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med 1992; 175: 637-646.
9. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993; 14: 436-441.
10. Barnes PJ, Karin M. Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071.
11. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994; 91: 752-756.
12. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol Cell Biol 1995; 15: 943-953.
13. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 1995; 270: 283-286.
14. Granelli-Piperno A, Nolan P, Inaba K et al. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites in the interleukin 2 promoter. J Exp Med 1990; 172: 1869-1872.
15. Griffin PJA, Gomes DA. Costa CA, Salaman JR. A controlled trial of steroids in cyclosporine-treated renal transplant recipients. Transplantation 1987; 43: 505-508.
16. MacDonald AS, Daloze P, Dandavino R et al. A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Transplant Proc 1987; 19: 1865-1867.
17. Johnson RWG, Mallick NP, Bakran A et al. A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Transplant Proc 1989; 21: 1581-1582.
18. Schulak JA, Mayes JT, Moritz CE, Hricik DE. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine and azathioprine treated renal transplant patients. Transplantation 1990; 49: 327-332.
19. Sinclair NR, Canadian Multicenter Transplant Study Group. Low dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. Can Med Assoc J 1992; 147: 645-655.
20. Ratcliffe PJ, Dudley CRK, Higgins RM, Firth JD, Smith B, Morris PJ. Randomized controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996; 348: 643-648.
21. Hollander AMJ, Hene RJ, Hermans J, Van Es LA, Van der Woude FJ. Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study. J Am Soc Nephrol 1997; 8: 294-301.
22. Steroid Withdrawal Study Group. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - a prospective randomized study. Transplantation 1999; 68: 1865-1874.
23. Vanrenterghem Y, Lebranchu Y, Hene R, Oppenheimer F, Ekberg H for the Steroid Dosing Study Group. Double-blind comparison of two cortiosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 2000; 70: 1352-1359.
24. Cole E, Landsberg D, Russell D et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation, 2001; 72: 845-850.
25. Birkeland SA. Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate maintenance therapy. Transplantation 1998; 66: 1207-1210.
26. Vincenti F, Monaco A, Grinyo J et al. Rapid steroid withdrawal versus standard steroid treatment in patients treated with Simulect, Neoral, and Cellcept for the prevention of acute rejection in renal transplantation: a multicenter, randomized trial [abstract]. Transplantation 2000; 69 (Suppl.): S133.
27. Shapiro R, Jordan ML, Scantlebury VP et al. Outcomes after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 1998; 30: 1375-1377.
28. Woodle ES, Buell J, Siegel C, Kulkarni S, Kopelan A, Grewal HP. Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience. Transplant Proc 1999; 31 (Suppl.): 84S-85S.
29. Kaufman DB, Leventhal JR, Fryer JP, Abecassis M'I, Stuart FP. Kidney transplantation without prednisone [abstract]. Transplantation 2000; 69 (Suppl. 1): S133.
30. Sarwal MM, Yorgin PD, Alexander S et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001; 72: 13-21.
31. Mahalati K, Kahan BD. An open-labeled pilot study of steroid withdrawal from kidney transplant recipients on sirolimus-cyclosporine combination. Am J Transplantation 2001; 1 (Suppl. 1): 247.
32. Hricik DE, Whalen C, Lautman J, Bartucci MR, Moir EJ, Mayes JT, Schulak JA. Withdrawal of steroids after renal transplantation: clinical predictors of outcome. Transplantation 1992; 53: 41-45.
33. Smiley ST, Csizmadia V, Gao W, Turka LA, Hancock WW. Differential effects of cyclosporine A, methylprednisolone, mycophenolate mofetil and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance. Transplantation 2000; 70: 415-421.